Literature DB >> 12584044

Adoptive T cell therapy--immune monitoring and MHC multimers.

Cassian Yee1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12584044     DOI： 10.1016/s1521-6616(02)00015-3

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  3 in total

1.  Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.

Authors:  Catriona H T Miller; Laura Graham; Harry D Bear
Journal:  BMC Immunol       Date:  2010-11-04       Impact factor: 3.615

2.  IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo.

Authors:  Esther Cha; Laura Graham; Masoud H Manjili; Harry D Bear
Journal:  Breast Cancer Res Treat       Date:  2009-10-14       Impact factor: 4.872

3.  Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.

Authors:  Hanh K Le; Laura Graham; Catriona H T Miller; Maciej Kmieciak; Masoud H Manjili; Harry Douglas Bear
Journal:  Cancer Immunol Immunother       Date:  2009-02-06       Impact factor: 6.968
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.